• Doxepin, Urine
  • Programmed death-ligand 1 (PD-L1) by Immunohistochemistry (IHC)
  • Methohexital, Urine
  • B-Cell Acute Lymphoblastic Leukemia (ALL), FISH, Bone Marrow
  • Zaleplon, Urine
  • Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS
  • Measles (Rubeola) Antibody, IgG
  • Biopsy, Lymph Node
  • BRCA1 and BRCA2 Gene Mutations Analysis (duplication/deletion and large gene rearrangements)
  • Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication (OvaNext®)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Weak D
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Weak D
Medical Test

Overview
Access to Weak D is restricted.